688
Views
0
CrossRef citations to date
0
Altmetric
Clinical Studies

Decrease in platelet count in patients with AKI and its association with major adverse kidney events

ORCID Icon, ORCID Icon, , , , , , , , , , ORCID Icon, ORCID Icon, , , ORCID Icon & ORCID Icon show all
Article: 2359643 | Received 28 Dec 2023, Accepted 20 May 2024, Published online: 13 Jun 2024

References

  • Thomas MR, Storey RF. The role of platelets in inflammation. Thromb Haemost. 2015;114(3):1–11. PMID: 26293514. doi:10.1160/TH14-12-1067.
  • Franco AT, Corken A, Ware J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood. 2015;126(5):582–588. PMID: 26109205; PMCID: PMC4520875. doi:10.1182/blood-2014-08-531582.
  • Lisman T. Platelet-neutrophil interactions as drivers of inflammatory and thrombotic disease. Cell Tissue Res. 2018;371(3):567–576. PMID: 29178039; PMCID: PMC5820397. doi:10.1007/s00441-017-2727-4.
  • Rivera J, Lozano ML, Navarro-Núñez L, et al. Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica. 2009;94(5):700–711. PMID: 19286885; PMCID: PMC2675683. doi:10.3324/haematol.2008.003178.
  • Estevez B, Du X. New concepts and mechanisms of platelet activation signaling. Physiology (Bethesda). 2017;32(2):162–177. PMCID: PMC5337829. doi:10.1152/physiol.00020.2016.
  • Jain N, Corken AL, Kumar A, et al. Role of platelets in chronic kidney disease. J Am Soc Nephrol. 2021;32(7):1551–1558. PMID: 34140394; PMCID: PMC8425650. doi:10.1681/ASN.2020121806.
  • Kertai MD, Zhou S, Karhausen JA, et al. Platelet counts, acute kidney injury, and mortality after coronary artery bypass grafting surgery. Anesthesiology. 2016;124(2):339–352. PMCID: PMC5040517. doi:10.1097/ALN.0000000000000959.
  • Chávez-Iñiguez JS, García-García G, Lombardi R. [Epidemiología y desenlaces de la lesión renal aguda en latinoamérica]. Gac Med Mex. 2018;154(Supp 1):S6–S14. Spanish. doi:10.24875/GMM.M18000067.PMID: 30074021.
  • Chávez-Íñiguez JS, Madero M. Global perspectives in acute kidney injury: Mexico. Kidney360. 2022; 3(4):737–739. PMID: 35721615; PMCID: PMC9136888. doi:10.34067/KID.0006592021.
  • Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411–1423. PMID: 26162677. doi:10.1007/s00134-015-3934-7.
  • Guo Q, Lou Y, Liu L, et al. How can I manage thrombocytopenia in hemodialysis patient? A review. Ther Apher Dial. 2020;24(4):352–360. PMID: 31661590. doi:10.1111/1744-9987.13448.
  • Kellum JA, Lameire N, Aspelin P, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1–138.
  • von Elm E, Altman DG, Egger M, et al. Declaración de la iniciativa STROBE (strengthening the reporting of observational studies in epidemiology): directrices Para la comunicación de estudios observacionales [The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies]. Rev Esp Salud Publica. 2008;82(3):251–259. Spanish. PMID: 18711640. doi:10.1590/s1135-57272008000300002.
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810. PMID: 26903338; PMCID: PMC4968574. doi:10.1001/jama.2016.0287.
  • Daugirdas JT, Bernardo AA. Hemodialysis effect on platelet count and function and hemodialysis-associated thrombocytopenia. Kidney Int. 2012;82(2):147–157. PMID: 22592187. doi:10.1038/ki.2012.130.
  • Liu D, Czigany Z, Heij LR, et al. The value of platelet-to-lymphocyte ratio as a prognostic marker in cholangiocarcinoma: a systematic review and meta-analysis. Cancers (Basel). 2022;14(2):438. PMID: 35053599; PMCID: PMC8773915. doi:10.3390/cancers14020438.
  • Rossaint J, Margraf A, Zarbock A. Role of platelets in leukocyte recruitment and resolution of inflammation. Front Immunol. 2018;9:2712. PMID: 30515177; PMCID: PMC6255980. doi:10.3389/fimmu.2018.02712.
  • van der Meijden PEJ, Heemskerk JWM. Platelet biology and functions: new concepts and clinical perspectives. Nat Rev Cardiol. 2019;16(3):166–179. PMID: 30429532. doi:10.1038/s41569-018-0110-0.
  • Rubenstein DA, Yin W. Platelet-Activation mechanisms and vascular remodeling. Compr Physiol. 2018;8(3):1117–1156. doi:10.1002/cphy.c170049.PMID: 29978900.
  • Koupenova M, Clancy L, Corkrey HA, et al. Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circ Res. 2018;122(2):337–351. PMID: 29348254; PMCID: PMC5777300. doi:10.1161/CIRCRESAHA.117.310795.
  • Wang YQ, Wang B, Liang Y, et al. Role of platelet TLR4 expression in pathogensis of septic thrombocytopenia. World J Emerg Med. 2011;2(1):13–17. PMID: 25214976; PMCID: PMC4129734. doi:10.5847/wjem.j.1920-8642.2011.01.002.
  • Kam T, Alexander M. Drug-induced immune thrombocytopenia. J Pharm Pract. 2014;27(5):430–439. Epub 2014 Aug 17. PMID: 25134884. doi:10.1177/0897190014546099.
  • Baughman RP, Lower EE, Flessa HC, et al. Thrombocytopenia in the intensive care unit. Chest. 1993;104(4):1243–1247. PMID: 8404200. doi:10.1378/chest.104.4.1243.
  • Chávez-Íñiguez JS, Maggiani-Aguilera P, González-Barajas D, et al. Urea reduction in acute kidney injury and mortality risk. Kidney Blood Press Res. 2023;48(1):357–366. Epub ahead of print. PMID: 36972576. doi:10.1159/000530237.
  • Baaten C, Sternkopf M, Henning T, et al. Platelet function in CKD: a systematic review and meta-analysis. J Am Soc Nephrol. 2021;32(7):1583–1598. PMID: 33941607; PMCID: PMC8425648. doi:10.1681/ASN.2020101440.
  • Hu L, Tian K, Zhang T, et al. Cyanate induces oxidative stress injury and abnormal lipid metabolism in liver through Nrf2/HO-1. Molecules. 2019;24(18):3231. PMID: 31491954; PMCID: PMC6767610. doi:10.3390/molecules24183231.
  • Horowitz HI, Stein IM, Cohen BD, et al. Further studies on the platelet-inhibitory effect of guanidinosuccinic acid and its role in uremic bleeding. Am J Med. 1970;49(3):336–345. doi:10.1016/s0002-9343(70)80025-0.PMID: 5455565.
  • Zhu W, Buffa JA, Wang Z, et al. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk. J Thromb Haemost. 2018;16(9):1857–1872. PMID: 29981269; PMCID: PMC6156942. doi:10.1111/jth.14234.
  • Corona-de-la-Peña N, Uribe-Carvajal S, Barrientos-Rios R, et al. Polyamines inhibit both platelet aggregation and glycoprotein IIb/IIIa activation. J Cardiovasc Pharmacol. 2005;46(2):216–221. PMID: 16044034. doi:10.1097/01.fjc.0000171753.43564.7c.
  • Linthorst GE, Avis HJ, Levi M. Uremic thrombocytopathy is not about urea. J Am Soc Nephrol. 2010;21(5):753–755. PMID: 20360312; PMCID: PMC2865735. doi:10.1681/ASN.2009111181.
  • Ostertag LM, O’Kennedy N, Horgan GW, et al. In vitro anti-platelet effects of simple plant-derived phenolic compounds are only found at high, non-physiological concentrations. Mol Nutr Food Res. 2011;55(11):1624–1636. doi:10.1002/mnfr.201100135.PMID: 21898791.
  • Shashar M, Belghasem ME, Matsuura S, et al. Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk. Sci Transl Med. 2017;9(417):eaam8475. PMID: 29167396; PMCID: PMC5854487. doi:10.1126/scitranslmed.aam8475.
  • Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semin Thromb Hemost. 2004;30(5):579–589. PMID: 15497100. doi:10.1055/s-2004-835678.
  • Onwuemene O, Arepally GM. Heparin-induced thrombocytopenia: research and clinical updates. Hematol Am Soc Hematol Educ Program. 2016;2016(1):262–268. PMID: 27913490; PMCID: PMC6142447. doi:10.1182/asheducation-2016.1.262.
  • Bui VC, Nguyen TH. The role of Single-Molecule force spectroscopy in unraveling typical and autoimmune heparin-induced thrombocytopenia. Int J Mol Sci. 2018;19(4):1054. PMID: 29614814; PMCID: PMC5979551. doi:10.3390/ijms19041054.
  • Kobari E, Terawaki H, Takahashi Y, et al. Dialyzer-related thrombocytopenia due to a polysulfone membrane. Intern Med. 2016;55(8):965–968. PMID: 27086813. doi:10.2169/internalmedicine.55.5636.
  • Yang RC, Lindsay RM. Dialyzer reactions in a patient switching from peritoneal dialysis to hemodialysis. Hemodial Int. 2005;9(2):120–126. PMID: 16191059. doi:10.1111/j.1492-7535.2005.01123.x.
  • Posadas MA, Hahn D, Schleuter W, et al. Thrombocytopenia associated with dialysis treatments. Hemodial Int. 2011;15(3):416–423. PMID: 21711442. doi:10.1111/j.1542-4758.2011.00561.x.
  • Bacelar Marques ID, Pinheiro KF, de Freitas do Carmo LP, et al. Anaphylactic reaction induced by a polysulfone/polyvinylpyrrolidone membrane in the 10th session of hemodialysis with the same dialyzer. Hemodial Int. 2011;15(3):399–403. PMID: 21624039. doi:10.1111/j.1542-4758.2011.00553.x.
  • Reeves JH, Cumming AR, Gallagher L, et al. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration. Crit Care Med. 1999;27(10):2224–2228. PMID: 10548211. doi:10.1097/00003246-199910000-00026.
  • Ben Hamida C, Lauzet JY, Rézaiguia-Delclaux S, et al. Effect of severe thrombocytopenia on patient outcome after liver transplantation. Intensive Care Med. 2003;29(5):756–762. PMID: 12677370. doi:10.1007/s00134-003-1727-x.
  • Jonsson AB, Rygård SL, Hildebrandt T, et al. Thrombocytopenia in intensive care unit patients: a scoping review. Acta Anaesthesiol Scand. 2021;65(1):2–14. PMID: 32916017. doi:10.1111/aas.13699.
  • Hui P, Cook DJ, Lim W, et al. The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest. 2011;139(2):271–278. PMID: 21071526. doi:10.1378/chest.10-2243.
  • Williamson DR, Albert M, Heels-Ansdell D, et al. Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest. 2013;144(4):1207–1215. PMID: 23788287. doi:10.1378/chest.13-0121.
  • Strauss R, Wehler M, Mehler K, et al. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med. 2002;30(8):1765–1771. PMID: 12163790. doi:10.1097/00003246-200208000-00015.
  • Lin J, Gallagher M, Bellomo R, et al. SOFA coagulation score and changes in platelet counts in severe acute kidney injury: analysis from the randomized evaluation of normal versus augmented level (RENAL) study. Nephrology (Carlton). 2019;24(5):518–525. PMID: 29693303. doi:10.1111/nep.13387.
  • Vandijck DM, Blot SI, De Waele JJ, et al. Thrombocytopenia and outcome in critically ill patients with bloodstream infection. Heart Lung. 2010;39(1):21–26. PMID: 20109983. doi:10.1016/j.hrtlng.2009.07.005.
  • Xu X, Wang H, Wu X, et al. [Risk factors of early septic shock-related thrombocytopenia and its impact on prognosis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021;33(8):938–943. PMID: 34590560. doi:10.3760/cma.j.cn121430-20210112-00036.